FDA approves remestemcel-L-rknd for steroid-refractory acute graft versus host disease in pediatric patients

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-remestemcel-l-rknd-steroid-refractory-acute-graft-versus-host-disease-pediatric